Timothy Ayotte is an associate in Nixon Peabody’s M&A and Corporate Transactions practice group and a member of the firm’s Life Sciences team.
I advise companies on a variety of corporate matters, particularly in connection with mergers, acquisitions, joint ventures, financing transactions and other complex commercial transactions. I have extensive experience working with companies in the life sciences industry.
Prior to joining Nixon Peabody, I served as associate counsel at Alere Inc. (a division of Abbott Laboratories since October 2017), a global manufacturer of diagnostic tests for infectious disease, cardiometabolic disease and toxicology in the U.S. and internationally.
I anticipate that the competitive nature of the health care, information management and financial services industries will continue to reward companies who can deploy innovative strategies for expanding product and service offerings, reducing barriers to access and controlling costs. I believe that companies in the life sciences and other technology–driven sectors will increasingly view strategic M&A transactions as a valuable tool for pursuing these goals.